Aerocrine’s rights issue oversubscribed
Not for publication, release or distribution, directly or indirectly, in or into the United States, Canada, Australia, Hong Kong, Singapore, South Africa, Japan or New Zealand. Aerocrine’s rights issue with pre-emptive rights for the company's shareholders and the holders of the company’s convertible bonds 2010/2015 has been oversubscribed and the underwriting commitments will, accordingly, not be utilized. The subscription period of the rights issue ended on May 11, 2012. Approximately 98.6 per cent of the issued shares were subscribed for with subscription rights and an additional